Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04828954
Other study ID # IRB20-1651
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 19, 2021
Est. completion date August 4, 2024

Study information

Verified date June 2023
Source University of Chicago
Contact Andrew Straszewski, MD
Phone 773-834-3531
Email Andrew.Straszewski@uchospitals.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Thumb carpometacarpal (CMC) osteoarthritis (OA) is common, seen frequently in middle-aged and elderly women. While a variety of surgical treatments have been described with none superior to any other, there is no consensus on the optimal duration of postoperative immobilization. Immobilization following surgery is critical for wound healing, pain control, and aid with activities of daily living in the early recovery period, though the duration of this must be weighed against the negative impacts of immobilization, such as stiffness, contracture, and delay in return to full function. The information gained in this study may allow hand surgeons to use an evidence-based postoperative rehabilitation protocol. Thus, our goal is to compare varying durations of postoperative immobilization after thumb CMC arthroplasty in a randomized trial design. Subjects will be randomized to treatment with non-removable thumb spica plaster postoperative splint immobilization for 2 weeks or non-removable thumb spica plaster splint transitioned to cast for a total of 6 weeks immobilization following base of thumb arthroplasty. Patient-reported outcome measures (PROs) and objective metrics will be tracked in the follow-up period.


Description:

Thumb CMC OA is common, with radiographic prevalence ranging from 7% to 35% in the literature, with symptomatic OA affecting 2% to 6% of the population. There is predilection for involvement of the non-dominant hand, and thumb CMC OA is the leading cause of hand pain due to degenerative changes. Gender-specific differences in thumb CMC OA prevalence have also been described in the literature. Retrospective review of 615 patients revealed a 6-fold higher prevalence of thumb basilar joint OA for females in nearly every age group, noting the presence of radiographic OA at younger ages in females, and quicker progression to end-stage degenerative changes. While conservative treatment, such as injections, therapy, splinting, and pharmacotherapy, may palliate symptoms, operative intervention is recommended if symptoms are persistent. Trapeziectomy with or without suspensionplasty is most commonly performed for advanced osteoarthritis, and studies have shown that trapeziectomy with ligament reconstruction and tendon interposition (LRTI) is the most frequently performed procedure. Because of the extensive nature of this surgery with dissection and removal of the trapezium as a common central procedure, immobilization of the thumb and wrist has been a standard part of postoperative protocols to improve postoperative pain, function, and aid with return to daily activities. Across many studies of operative technique and post-surgical care, there is no high-level evidence on the optimal duration of postoperative immobilization. With no consensus on the duration during which patients should restrict range of motion after thumb CMC joint surgery, there is a gap in knowledge on this topic. Immobilization following surgery is critical for wound healing, pain control, and aid with activities of daily living in the early recovery period, though the duration of this must be weighed against the negative impacts of immobilization, such as stiffness, contracture, and delay in return to full function. The information gained in this study may allow hand surgeons to use an evidence-based postoperative rehabilitation protocol. Thus, our goal is to compare varying durations of postoperative immobilization after thumb CMC arthroplasty in a randomized trial design. In this study, we will prospectively evaluate varied duration of postoperative immobilization in patients older than 40 years, undergoing base of thumb arthroplasty at an academic, tertiary referral center. Patients will be randomized to either 2 or 6 weeks of immediate postoperative immobilization in a plaster thumb spica splint or cast. Functional outcome measures, including quickDASH (Disabilities of Arm, Shoulder, and Hand), PROMIS UE (Patient Reported Outcome Measures Information System Upper Extremity) form, and VAS (Visual Analog Scale) pain scale will be captured at short-term, intermediate-term, and final follow-up periods. Additionally, exploratory objective metrics, such as strength, range of motion (ROM), return to work, and occupational therapy (OT) utilization will be monitored at all time periods. Randomization into two cohorts of postoperative rehabilitation will occur via sealed envelope at the time of surgery. Patients will be consented through a formal written process detailing the purpose, risks, and benefits. Randomization will occur in a 1:1 ratio into 2-week versus 6-week immobilization groups. Opaque envelopes will be sealed and only opened at the time of randomization, immediately after completion of the surgical procedure, in the post-anesthesia care unit (PACU). Every patient will be immobilized postoperatively in a nonremovable thumb spica plaster splint to allow for swelling. At the 2 week (+/- 3 days) postoperative visit, patients will be placed into either a cast for 4 additional weeks of immobilization (6-week immobilization group) or be provided a removable thermoplastic thumb spica splint (2-week immobilization group) and specifically instructed to use it for comfort "as needed" with removal at their discretion. A similarly fashioned thermoplastic thumb spica splint will be provided to the 6-week group after the duration of their immobilization, again with instructions for "as needed" use. At the conclusion of each group's respective immobilization period, the same standardized hand therapy rehabilitation regimen will be initiated.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date August 4, 2024
Est. primary completion date May 4, 2024
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility Inclusion Criteria: - Age >= 40 years old - Patients undergoing arthroplasty of the first CMC joint including: 1. Trapeziectomy with LRTI 2. Simple Trapeziectomy 3. Suspensionplasty (suture vs. APL) Exclusion Criteria: - Patients < 40 years of age - Patients who have undergone prior surgical procedures on the thumb base - Patients with history of prior procedure at the base of thumb, or those with plan for concomitant carpal tunnel release or thumb metacarpophalangeal (MCP) arthrodesis, will be excluded. Concomitant carpal tunnel surgery may skew outcome surveys, and an arthrodesis procedure will warrant a longer length of immobilization following procedure. - Those undergoing implant arthroplasty - Patients with a diagnosis of inflammatory arthritis - Patients with diagnosis of hypermobility syndrome

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Immobilization for 2-weeks postoperative
Non-removable thumb spica plaster postoperative splint immobilization worn for 2 weeks
Immobilization for 6-weeks postoperative
Non-removable postoperative thumb spica splint immobilization worn for 2 weeks (+/- 3 days), to be transitioned to thumb spica cast for an additional 4 weeks (Total of 6 weeks immobilization)

Locations

Country Name City State
United States University of Chicago Medicine Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quick Disabilities of Arm, Shoulder, and Hand (quickDASH) Questionnaire scores The 11 question disability survey will be scored if at least 10 of the items are completed. The average score of responses (maximum of 5) will be obtained and transformed into score of 0 to 100 by subtracting one and multiplying by 25. A higher score indicated greater disability. The scores between treatment arms will be compared, as well as comparison of baseline scores with subsequent follow-up scores within each treatment arm. Administered at baseline visit, and 2-week, 6-week, 3-month and 1-year post-operative follow up visits. Change from baseline quickDASH to 3-months
Secondary Visual Analog Scale (VAS) Pain scale Visual analog pain scale where scores of "0" indicate no pain and scores of "10" indicate maximum pain. The scores between treatment arms will be compared, as well as comparison of baseline scores with subsequent follow-up scores within each treatment arm. Administered at baseline visit, and 2-week, 6-week, 3-month and 1-year post-operative follow up visits. Change from baseline VAS to 3-months
Secondary Patient-Reported Outcome Measures Information System (PROMIS) Upper Extremity scores PROMIS Upper Extremity scores will be obtained via IPAD at baseline, 2-week, 6-week, 3-month, and 1-year follow-up appointments. The PROMIS domains are obtained via computer adaptive testing (CAT) with a mean of 50 and standard deviation of 10 for reference populations. A higher score indicates greater function. The scores between treatment arms will be compared, as well as comparison of baseline scores with subsequent follow-up scores within each treatment arm. Administered at baseline visit, and 2-week, 6-week, 3-month and 1-year post-operative follow up visits. Change from baseline PROMIS to 3-months
See also
  Status Clinical Trial Phase
Completed NCT04913935 - Investigation of Thenar Muscles Morphometric Parameters in Patients With TMC OA
Terminated NCT04613154 - Magnesium as an Adjunct for Pain Treatment After Surgery for Thumb Base Arthrosis N/A
Not yet recruiting NCT06401317 - Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA) N/A
Completed NCT05772715 - The THumb Osteoarthritis Exercise TriAl N/A
Not yet recruiting NCT05095415 - Occupational Therapy Pre-operative Education in the Orthopedic Hand Setting N/A
Active, not recruiting NCT03611023 - Study of the Touch® Trapezo-metacarpal Prosthesis
Completed NCT03858946 - Ligament Reconstruction Weilby vs Simple Trapeziectomy N/A
Recruiting NCT05626192 - Anatomical Evaluation of the APL Tendons in Thumb CMC Joint and Osteoarthritis
Recruiting NCT04892589 - The Role of the Proprioceptive Training in Functional Recovery of Patient With Thumb Base Osteoarthritis
Recruiting NCT04210687 - Trapeziectomy vs. Trapeziometacarpal Limited Excision for Thumb Base Osteoarthritis N/A
Recruiting NCT04826380 - Thumb Basal Joint (CMC I) Arthritis - Preoperative Anxiety/Depression, Outcome Instruments, Carpal Cinematics and Cost-utility N/A
Completed NCT04738201 - Proprioceptive Thumb Exercises Program in Patients With Carpometacarpal Joint Osteoarthritis N/A
Recruiting NCT04625244 - Can Video Assisted Therapy Replace In-Person Occupational Therapy After Hand Surgery: A Noninferiority Study N/A
Recruiting NCT01679717 - Postoperative Therapy After Interposition Arthroplasty in CMC1 N/A
Active, not recruiting NCT05315297 - Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis N/A
Not yet recruiting NCT05896410 - 3D-Printed Hand Orthosis Versus Thermoplastic Orthosis N/A
Not yet recruiting NCT04588961 - Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis N/A
Recruiting NCT05992883 - NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis Phase 3
Completed NCT02958137 - Arthroscopic Resection Arthroplasty of Carpometacarpal and/or Pantrapezial Osteoarthritis N/A
Recruiting NCT05127005 - Efficacy of Trapeziectomy Versus Sham Surgery in the Treatment of Osteoarthritis at the Base of the Thumb N/A